• YAKHAK HOEJI
• /
• v.48 no.1
• /
• pp.20-26
• /
• 2004

Twelve strains of Bifidobacterium spp. were isolated from the feces of healthy Korean 20∼30 years. The identification of genera from isolates were performed by the microscopic observation and fructose-6-phosphate phosphoketolase (F6PPK) activity which is the key enzyme to distinguish the Bifidobacterium spp. from other anaerobic bacteria. To determine the antibacterial resistance patterns, minimum inhibitory concentration (MIC) of several antibiotics (including anti-tuberculosis agents) was determined. Five of the isolate!, showed the high degree of resistance to vancomycin. To investigate the genetic diversity between isolates and type strain of Bifidobacterium spp. from KCTC, we peformed the RAPD-fingerprinting. Using a total set of four primers, it is possible to distinguish the isolates and Bifidobacterium spp. from KCTC. Thus, Bifidobacterium strains isolated from our samples may be a new species or strains of Bifidobacteriurn genera, and have the potential as a probiotics.

• Journal of Dairy Science and Biotechnology
• /
• v.12 no.1
• /
• pp.20-27
• /
• 1994

건강한 성인의 분변으로 부터 호기적인 평판배지에서의 생육이 가능한 비피더스균을 선별 분리하는 조건과 상기 분리주의 특성을 규명한 결과는 다음과 같다. 1.5%의 탈섬유소 말혈액을 첨가한 BLB Agar Medium에 인체 분변을 호기적으로 표면 배양하여 내산소성 비피더스균 변이주를 분리하였다. 상기 분리주는 BLB Agar Medium 평판배지에 호기적으로 배양 했을때 $1.1\;{\times}\;10^9$ cfu/ml 이상의 높은 균수를 유지하였다. 2. 상기의 내산소성 비피더스균 분리주를 BLB Agar Medium 에 호기적으로 배양했을때 0.5mm, 연유갈색, 원형, 융기상의 윤택한 집락을 형성하였으며 현미경 검경 결과 Y 자형 분지상과 V자형 만곡간균상, 팽윤상 등의 전형적인 비피더스균 형상으로 나타냈다. 3. 탄수화물 발표실험 결과 상기의 내산소성 비피더스균 분리주는 Bif. adolescentis 로 동정되었으며 F6PPK GKA효소 활성 함께 매우 높은 ${\alpha}$-Galactosidase, $\beta$ - Galactosidase, ${\alpha}$-Galactosidase, 효소 활성을 나타냈다. 한편 아무것도 첨가하지 않은 순수한 우유 중에서의 발효성 및 호기적인 생육능이 매우 양호하였다.

• Korean Journal of Food Science and Technology
• /
• v.36 no.5
• /
• pp.790-794
• /
• 2004

Bifidobacterium spp. exhibits the highest number of counts among species of microflora in breast-feeding infant intestines and has been used as probiotics. From infant groups with different diets, 42 Bifidobacterial strains were isolated by selective plate, Gram-staining, and morphology using method of Mitsuoka, among which seven isolates were identified as Bifidobacterium spp. by F6PPK test, MIDI, and PCR. B. bifidum PBH-30, selected for development of probiotics, showed high resistance against low pH and oxgall treatment, and inhibition against pathogens such as Salmonella typhimurium and Staphylococcus aureus. B. bifidum PBH-30 could be applicable to dairy products as probiotic strains due to its excellent growth in raw milk.

• Journal of Microbiology and Biotechnology
• /
• v.28 no.11
• /
• pp.1846-1849
• /
• 2018

Recent human gut microbiome studies have supported that the genus Bifidobacterium is one of the most beneficial bacteria for human intestinal health. To develop a new probiotic strain for functional food applications, fourteen fecal samples were collected from healthy Koreans and the strain BCBR-583 was newly selected and isolated from a 25-year-old Korean woman's fecal sample using the selective medium for Bifidobacterium. Subsequent fructose-6-phosphate phosphoketolase (F6PPK) test and 16S rRNA gene sequencing analysis of the strain BCBR-583 confirmed that it belongs to B. longum subsp. longum. The stress resistance tests showed that it has oxygen and heat tolerance activities (5- and 3.9-fold increase for 24 h at 60 and 120 rpm, respectively; $78.61{\pm}6.67%$ survival rate at $45^{\circ}C$ for 24 h). In addition, gut environment adaptation tests revealed that this strain may be well-adapted in the gut habitat, with gastric acid/bile salt resistance ($85.79{\pm}1.53%$, survival rate under 6 h treatments of gastric acid and bile salt) and mucin adhesion ($73.72{\pm}7.36%$). Furthermore, additional tests including cholesterol lowering assay showed that it can reduce $86.31{\pm}1.85%$ of cholesterol. Based on these results, B. longum BCBR-583 has various stress resistance for survival during food processing and environmental adaptation activities for dominant survival in the gut, suggesting that it could be a good candidate for fermented food applications as a new probiotic strain.

• Journal of Microbiology and Biotechnology
• /
• v.12 no.1
• /
• pp.176-181
• /
• 2002

In order to isolate and identify Bifidobacterium spp. that originated in Korea, feces were sampled from healthy Korean adults and children living in three villages, the first having a history of longevity and the other two where the diet did not include fermented milk or any pharmaceutical preparations. Through the use of Gram staining and microscopic examination for cell morphology, 23 bacterial strains presumed to be the Bifidobacterium genus were isolated from the feces of 13 out of a total of 59 Korean people. To identify the Bifidobacterium strains at the genus level, these bacteria were then analyzed by TLC and the fructose-6-phosphate phosphoketolase (F6PPK) test. The result showed that 22 of the isolated strains were confirmed to be members of the genus Bifidobacterium. All of these bifidobacteria were also identified as Bifidobacterium spp. by the fermentation test. Using a RFLP analysis, an attempt was made to identify the Bifidobacterium spp. that had been isolated from both Korean adults and children. In a genomic Southern blot analysis after digestion with two restriction enzymes (EcoRI, HindIII), all of the 14 randomly selected Korean isolates showed patterns identical to those of three different B. longum species. Another restriction enzyme, CfoI (4-bp recognition enzyme), was then used to identify the strain. Interestingly, all the Korean isolates were identified as B. longum ATCC 15708, indicating that a RFLP analysis was effective for identifying Bifidobacterium spp. at both the strain and species levels.